Objectives

​

  Target participants: 

•  Oncology pharmacists, clinical pharmacists and other pharmacy staff.

• All healthcare professionals interested in oncology. 

​

 Objectives: To familiarize participants with the following concepts:

​

• NTRK concept and TRK inhibitors.

• Test optimization for NTRK detection.

• Economics of oncology targeted therapy 

• Recent updates in management of colorectal cancer, RCC, gastric cancer, bladder cancer and prostate cancer.

• Cognitive disorders in cancer patients.

​

​

Faculty 

​

Nagwa Ibrahim, Pharm D, PhD

Chair, 2nd OPMC 2020 - Part 1

Senior Clinical Pharmacist, Oncology

Prince Sultan Military Medical City

Riyadh, Saudi Arabia

​

Abdullah Alsharm, MD

Medical Director of Comprehensive Cancer Center

King Fahd Medical City

Riyadh, Saudi Arabia

​

Alexandre Chan, Pharm.D., MPH, FCCP, FISOPP, BCPS, BCOP

Professor of Clinical Pharmacy

Founding Chair, Department of Clinical Pharmacy Practice

University of California, Irvine

Past President, International Society of Oncology Pharmacy Practitioners

Associate Editor, Journal of Oncology Pharmacy Practice

California, USA

​

Mohammed Alghamdi, MD

Consultant, Adult Medical Oncologist

Head, Medical Oncology Unit 

Oncology Center
King Saud University Medical City.
Riyadh, Saudi Arabia 

​

Fatima Mariki, Pharm D, BCOP, MSc Health Economic

Oncology Specialist Clinical Pharmacist

King Faisal Speciality Hospital and Research Center

Riyadh, Saudi Arabia

​

Saeed Al Turki, MD, PhD, FACMGG

Consultant of Molecular Genetics, Genomics & Bioinformatics

Head, Translational Pathology Section

Department of Pathology & Laboratory Medicine MC-1122

King Abdulaziz Medical City

Riyadh, Saudi Arabia

​

Hanna Al Abdulkarim, Rph, MSc

Director Drug Policy and Economic Center

National Guards Health Affairs

Riyadh, Saudi Arabia

​

Mohammad Al Nahedh, Pharm D, BCOP

Acting Head, Oncology Pharmacy Services

Clinical Pharmacy Specialist, Hematology/Oncology

King Faisal Specialist Hospital & Research Center

Riyadh, Saudi Arabia

​

Mansoor Ahmed Khan, BS, MS, BCOP

Senior Clinical Pharmacist, Adult Oncology/Hematology/BMT

Pharmaceutical Care Department, KAMC-WR

National Guard Health Affairs

Jeddah, Saudi Arabia

 

Nora Al Khudair, BS Pharm, Pharm D

Clinical Pharmacist, Oncology/Hematology & SCT

Assistant Professor

King Saud University Medical City

Clinical Pharmacy Department

King Saud University

Riyadh, Saudi Arabia

​

Ashraf Farrag, MD, PhD

Consultant Medical Oncology

Prince Sultan Military Medical City

Riyadh, Saudi Arabia

Associate Professor

Assiut University, Egypt 

​

Dr. Gihan El-sisi, MSc, PhD

Lecturer Health Economics, Arab Academy for Science & Technology

Cairo University

Cairo, Egypt

​

Dr. Sherif AlSemany, MD

Consultant Medical Oncologist 

King Abdullah Medical Center

Saudi Arabia

​

​

​

Topics:

 

Novel systemic treatment approaches in metastatic RCC

Dr. Abdullah Alsharm (KFMC)

​

NTRK gene fusion as novel targets for cancer therapy and TRK inhibitors

Dr. Fatima Mariki (KFSH&RC)

​

NTRK testing: optimizing NTRK gene fusion detection 

Dr. Saeed Al Turki (NGHA)

​

Economics of targeted therapy in oncology

Dr. Hana Al Abdulkarim (NGHA)

​

Management of gastric cancer beyond the 1st line therapy

Dr. Nora Alkhudair (KSUMC)

​

Sequential therapy optimization in MCRC

Dr. Mohammed Alghamdi (KSUMC)

​

New horizons in management of metastatic bladder cancer

Dr. Ashraf Farrag (PSMMC)

​

Predictors for cancer related cognitive disorders

Prof Alexandre Chan (USA)

​

Management of 1L RCC in era of IO clinical humanistic and economic value

Dr. Mansoor Khan (NGHA-Jeddah)

​

Pharmaco-economic evaluation of targeted therapy in first lines treatment of mCRC

Dr. Jihan El-sisi (Egypt)

​

​

​